Recombinant DNA technology (genetic engineering) involves the isolation, manipulation, and re-introduction of DNA sequences from different organisms, enabling the creation of novel combinations of genetic material not found in nature. The core tools are: Restriction enzymes (molecular scissors that cut DNA at specific sequences), DNA ligase (molecular glue that joins DNA fragments), cloning vectors (DNA vehicles for introducing foreign genes into host cells), and host cells (bacteria, yeast, or mammalian cells that maintain and express the recombinant DNA). The basic workflow: isolate gene of interest → cut with restriction enzyme → insert into vector (also cut with same enzyme) → ligate to form recombinant vector → transform into host cells → select transformants → screen for correct insert → amplify and express the gene.

Cloning vectors are DNA molecules that can replicate autonomously within a host cell and can carry foreign DNA inserts. They serve as vehicles to introduce, maintain, and amplify foreign DNA in a host organism. Types of cloning vectors include: Plasmids (most common for small inserts up to ~10 kb), bacteriophage lambda (for inserts ~10-20 kb), cosmids (hybrid plasmid-phage vectors for ~35-45 kb inserts), BACs (Bacterial Artificial Chromosomes, up to 300 kb), and YACs (Yeast Artificial Chromosomes, up to 1 Mb — used for genome sequencing projects). Each vector must contain: An ori (origin of replication) that is functional in the chosen host cell, ensuring autonomous replication. A selectable marker allowing identification of host cells that have taken up the vector. A cloning site (restriction sites) where foreign DNA can be inserted.

In nature, bacteria can take up DNA from their environment in a process called natural transformation, but most laboratory strains of E. coli are not naturally competent for DNA uptake. Making bacteria artificially competent involves treating them with CaCl2 (calcium chloride) at cold temperatures, which disrupts the cell membrane and allows DNA to pass through. The competent cells are then mixed with recombinant plasmid DNA and subjected to heat shock (42°C for 30-90 seconds) followed by rapid cooling — this temperature change is thought to create pores in the membrane through which DNA enters. Cells are then cultured in rich liquid medium to allow expression of antibiotic resistance genes, and finally plated on agar containing the selective antibiotic. Only cells that successfully took up the plasmid (and express the antibiotic resistance gene) will form colonies — these are the transformants. Modern transformation methods also include electroporation (using brief high-voltage electric pulses to transiently permeabilise the cell membrane), which can achieve much higher transformation efficiencies.

Selectable markers serve a critical function in cloning experiments by allowing the researcher to distinguish the rare cells that have successfully taken up the vector from the vast majority that have not. Without selectable markers, finding transformed cells among millions of non-transformed ones would be essentially impossible. Antibiotic resistance markers work by expressing an enzyme that inactivates the antibiotic: beta-lactamase (encoded by ampR/bla gene) cleaves the beta-lactam ring of ampicillin, rendering it inactive; aminoglycoside phosphotransferase (encoded by kanR) phosphorylates and inactivates kanamycin. Beyond simply selecting for cells carrying the vector, researchers also need to distinguish cells carrying the vector WITH the correct insert from those carrying the vector WITHOUT an insert (self-ligated empty vector). Blue-white screening is a common method for this: the lacZ gene (encoding beta-galactosidase) is disrupted by inserting foreign DNA into the MCS within the lacZ gene. Cells with empty vector express functional lacZ → cleave X-gal substrate → blue colonies. Cells with insert-containing recombinant vector have disrupted lacZ → no functional beta-galactosidase → no X-gal cleavage → white colonies.